DNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosa.
about
Nonhuman primate models for HIV/AIDS vaccine developmentPoxvirus vectors as HIV/AIDS vaccines in humansThe evolution of poxvirus vaccinesAltering an artificial Gagpolnef polyprotein and mode of ENV co-administration affects the immunogenicity of a clade C HIV DNA vaccineNovel directions in HIV-1 vaccines revealed from clinical trialsExhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders.A novel HIV vaccine adjuvanted by IC31 induces robust and persistent humoral and cellular immunity.Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humansDifferential blood and mucosal immune responses against an HIV-1 vaccine administered via inguinal or deltoid injection.Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins.Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman PrimatesTransient Peripheral Immune Activation follows Elective Sigmoidoscopy or Circumcision in a Cohort Study of MSM at Risk of HIV Infection.Safety and immunogenicity of DNA prime and modified vaccinia ankara virus-HIV subtype C vaccine boost in healthy adults.Therapeutic and prophylactic DNA vaccines for HIV-1.Modified Vaccinia Virus Ankara Vector Induces Specific Cellular and Humoral Responses in the Female Reproductive Tract, the Main HIV Portal of Entry.A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles.HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-SpeciCD160-associated CD8 T-cell functional impairment is independent of PD-1 expression.Cell-Mediated Immune Predictors of Vaccine Effect on Viral Load and CD4 Count in a Phase 2 Therapeutic HIV-1 Vaccine Clinical Trial.DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNA.Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4+ T cells in active disease.Pathology-Based Research in Africa.
P2860
Q26861148-C473B770-5728-4133-A161-DB480C4916A1Q26995078-538F1FC1-DD92-44A6-BCAB-92A41F249F83Q26995905-8CD1BA3F-37A4-48A8-951C-5FC20DB772D0Q28482252-136C1AD1-BB6F-40F7-B895-2141796E1347Q33645528-C830725F-6D75-4459-AD74-886BE7AD059BQ34230483-DC0FD433-2A0A-4D58-B9C2-D819F8934A46Q34359593-781AE266-4AFA-4BC0-B168-086570CDBC7CQ35055188-88044DFE-DD49-4610-9EEC-B6D9174DF722Q35099609-CCB2B065-2E7C-44EE-B62A-E0AAA3F3B0E0Q35488175-47FFDFDB-654A-445E-BF81-48862878E2D9Q35914311-3C8388A7-9F21-4684-A988-255AD2E6638CQ36106653-EA1DDD94-140F-4F97-9C40-3F4A62B80577Q36668517-090BF383-333B-498B-8C58-322A62529D4EQ38088037-067714A4-2494-40DD-97B4-70DBCE614ED0Q38369341-56462C6C-5594-4DC2-AA58-51BB85A89307Q40220988-CBA90885-54FB-4093-B479-EEAEBF0E3F4CQ40339467-003E16FD-3528-41C2-86DF-7AA41FCCF502Q41726535-AC6BA874-DBEB-4D0A-8D9A-456BDC177C7EQ41926056-81931CA6-A748-4F5D-AA87-B1EA2498FD8FQ41995910-A161DB5C-2F74-409C-897E-FF05F1A2DBD1Q44318621-324353B8-61B0-4A32-94B3-24BB8616A2B2Q50140471-F96436BA-7410-4C5B-90FE-1737761C5DB1
P2860
DNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosa.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
DNA/NYVAC vaccine regimen indu ...... esponses in intestinal mucosa.
@ast
DNA/NYVAC vaccine regimen indu ...... esponses in intestinal mucosa.
@en
type
label
DNA/NYVAC vaccine regimen indu ...... esponses in intestinal mucosa.
@ast
DNA/NYVAC vaccine regimen indu ...... esponses in intestinal mucosa.
@en
prefLabel
DNA/NYVAC vaccine regimen indu ...... esponses in intestinal mucosa.
@ast
DNA/NYVAC vaccine regimen indu ...... esponses in intestinal mucosa.
@en
P2093
P2860
P50
P356
P1433
P1476
DNA/NYVAC vaccine regimen indu ...... responses in intestinal mucosa
@en
P2093
Gian Dorta
Hugh C Welles
Jim Tartaglia
Mariano Esteban
Matthieu Perreau
Michel Maillard
Olivia Hall
Pierre-Alexandre Bart
Ralf Wagner
Ricardo Martin
P2860
P304
P356
10.1128/JVI.00788-11
P407
P577
2011-07-20T00:00:00Z